Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 476, doi. 10.1007/s002620000138
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 9
Results: 7
1
2
Erratum: Cancer Immunol Immunother (2000) 49: 314–318.
- Published in:
- 2000
- Publication type:
- Erratum
3
Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcγRI and the epidermal growth factor receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 493, doi. 10.1007/s002620000142
- By:
- Publication type:
- Article
4
Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 469, doi. 10.1007/s002620000127
- By:
- Publication type:
- Article
5
Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 459, doi. 10.1007/s002620000143
- By:
- Publication type:
- Article
6
Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 485, doi. 10.1007/s002620000139
- By:
- Publication type:
- Article
7
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 9, p. 504
- By:
- Publication type:
- Article